EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study

David Rekhtman iD, Amit Iyengar, Cindy Song iD, Michaela Asher, Max Shin iD, Michael Catalano iD, Omar Toubat, Emma Morganroth, Alyson Brown, Joyce Wald, Aditya Parikh, Mauer Biscotti und 1 weitere

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2026. Verfasst von David Rekhtman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Heart-Assist Devices, Postoperative Complications, Graft Rejection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Microaxial flow pump devices are utilized as a bridge to heart transplantation for patients in advanced cardiogenic shock. Little is known about the impact of device duration on post‐transplant outcomes. This study aims to compare post‐transplantation outcomes based on duration of support with the Impella 5.5.

Methods

All patients who were successfully bridged to transplant on the Impella 5.5 platform were included and stratified based on support duration (≤ 14 days vs. > 14 days). Baseline clinical characteristics were collected throughout the index admission. Outcomes included 1‐year mortality, complications during the index admission, graft rejection, and rehospitalization within the first year.

Results

Of the 72 patients successfully bridged to transplant, 64% (n = 46) were supported for more than 14 days. When stratified by duration of Impella 5.5 use, there were no differences in pretransplantation clinical status. Length of stay (26 vs. 20 days, p = 0.316) and rates of home discharges (65% vs. 67%, p = 0.524) were similar. Despite a high prevalence of rehospitalization at 1 year (75%), the 1‐year survival was 96% and similar between the two cohorts ( p = 0.289).

Conclusions

Use of a prolonged microaxial flow pump may be a safe bridging strategy for heart transplantation given comparable post‐transplant outcomes for patients stratified by support duration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationHeart-Assist DevicesPostoperative ComplicationsGraft RejectionHeart FailureShock, CardiogenicHumansFemaleMaleFollow-Up StudiesMiddle AgedSurvival RatePrognosisGraft SurvivalRetrospective StudiesRisk FactorsTime FactorsLength of StayBridge Therapy

Stichwörter der Autor:innen

heart failureheart transplantationtemporary mechanical circulatory support

Autor:innen und Institutionen

  • Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: David Rekhtman, Cindy Song, Max Shin, Michael Catalano

Zitieren

APA

Rekhtman, D., Iyengar, A., Song, C., Asher, M., Shin, M., Catalano, M., Toubat, O., Morganroth, E., Brown, A., Wald, J., Parikh, A., Biscotti, M., & Cevasco, M. (2026). Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study. Clinical Transplantation. https://doi.org/10.1111/ctr.70452

Vancouver

Rekhtman D, Iyengar A, Song C, Asher M, Shin M, Catalano M, et al. Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study. Clinical Transplantation. 2026. doi:10.1111/ctr.70452

BibTeX
@article{Rekhtman2026,
  author = {Rekhtman, David and Iyengar, Amit and Song, Cindy and Asher, Michaela and Shin, Max and Catalano, Michael and Toubat, Omar and Morganroth, Emma and Brown, Alyson and Wald, Joyce and Parikh, Aditya and Biscotti, Mauer and Cevasco, Marisa},
  title = {Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70452}
}
Kostenlos starten →